Studying How The Blind Perceive Race
By Kat Chow,
NPR
| 09. 29. 2013
[Discusses the work of CGS's Osagie Obasogie]
Law professor Osagie Obasogie walked into a movie theater to see "Ray," a biopic about the musician Ray Charles, and walked out with a question that would drive eight years worth of research.
"I was really struck by how Ray Charles had this really interesting understanding of race throughout his life even though he was blind throughout his early childhood," says Obasogie, who teaches at the University of California, Hastings College of the Law. "I just wanted to learn more about how blind people understood race. I never had thought about it."
Obasogie started by interviewing 110 individuals who were blind since birth. His full research on the topic will be published in a book, Blinded by Sight: Seeing Race in the Eyes of the Blind, that hits shelves in November.
The professor mentioned that some of the individuals he interviewed took offense at the notion that sighted people would think blind people are unaware of race. And that not being aware of race somehow made blind people morally superior.
Race factors into so much of our everyday...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...